• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状 RNA hsa_circ_0011298 通过调控 miR-486-3p/CRABP2 轴增强非小细胞肺癌对紫杉醇的耐药性。

Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis.

机构信息

The Second Internal Medicine Department, Dongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.

出版信息

J Clin Lab Anal. 2022 May;36(5):e24408. doi: 10.1002/jcla.24408. Epub 2022 Apr 8.

DOI:10.1002/jcla.24408
PMID:35396749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9102507/
Abstract

BACKGROUND

Circular RNAs (circRNAs) serve as critical regulators in the chemoresistance of human cancers, including non-small cell lung cancer (NSCLC). We aimed to explore the role of hsa_circ_0011298 (circ_0011298) and its mechanism in Taxol resistance of NSCLC.

METHODS

Circ_0011298, microRNA-486-3p (miR-486-3p), and CRABP2 mRNA expression were determined using qRT-PCR. EdU and MTT assays were used to detect cell proliferation. Cell cycle distribution and cell apoptosis were detected by flow cytometry. Cell migratory and invasive abilities were detected using transwell assay. Cellular glycolysis was determined by specific kits. Protein levels were examined by western blot. Dual-luciferase reporter and RIP assays were performed to confirm the relationship between miR-486-3p and circ_0011298 or CRABP2. Xenograft mice model was established to confirm the function of circ_0011298 in vivo.

RESULTS

Circ_0011298 was overexpressed in Taxol-resistant NSCLC cells and tissues. Circ_0011298 knockdown enhanced Taxol sensitivity by decreasing cell proliferation, migration, invasion, and glycolysis and inducing apoptosis and cell cycle arrest in Taxol-resistant NSCLC cells. Circ_0011298 was a sponge of miR-486-3p, and the impact of circ_0011298 silencing on Taxol resistance was rescued by miR-486-3p inhibition. Moreover, miR-486-3p directly targeted CRABP2, and miR-486-3p inhibited Taxol resistance by targeting CRABP2. Furthermore, circ_0011298 regulated CRABP2 expression through targeting miR-486-3p. Importantly, circ_0011298 interference elevated Taxol sensitivity of NSCLC in vivo.

CONCLUSION

Circ_0011298 elevated Taxol resistance of NSCLC by sponging miR-486-3p and upregulating CRABP2, providing a possible circRNA-targeted therapy for NSCLC.

摘要

背景

环状 RNA(circRNAs)作为人类癌症(包括非小细胞肺癌(NSCLC))化疗耐药性的关键调节剂。我们旨在探索 hsa_circ_0011298(circ_0011298)及其在紫杉醇耐药性 NSCLC 中的作用机制。

方法

采用 qRT-PCR 检测 circ_0011298、microRNA-486-3p(miR-486-3p)和 CRABP2 mRNA 表达。采用 EdU 和 MTT 检测细胞增殖。流式细胞术检测细胞周期分布和细胞凋亡。Transwell 检测细胞迁移和侵袭能力。特定试剂盒检测细胞糖酵解。Western blot 检测蛋白水平。双荧光素酶报告和 RIP 实验证实 miR-486-3p 与 circ_0011298 或 CRABP2 的关系。建立裸鼠移植瘤模型以证实 circ_0011298 在体内的功能。

结果

Circ_0011298 在紫杉醇耐药性 NSCLC 细胞和组织中高表达。Circ_0011298 敲低通过降低紫杉醇耐药性 NSCLC 细胞的增殖、迁移、侵袭和糖酵解,诱导细胞凋亡和细胞周期阻滞,增强紫杉醇敏感性。Circ_0011298 是 miR-486-3p 的海绵体,circ_0011298 沉默对紫杉醇耐药性的影响可通过 miR-486-3p 抑制得到挽救。此外,miR-486-3p 直接靶向 CRABP2,通过靶向 CRABP2 抑制紫杉醇耐药性。此外,circ_0011298 通过靶向 miR-486-3p 调节 CRABP2 表达。重要的是,circ_0011298 干扰可提高 NSCLC 裸鼠体内紫杉醇的敏感性。

结论

Circ_0011298 通过海绵吸附 miR-486-3p 和上调 CRABP2 来提高 NSCLC 的紫杉醇耐药性,为 NSCLC 提供了一种可能的环状 RNA 靶向治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/ca6de6973e02/JCLA-36-e24408-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/cd82085c25bc/JCLA-36-e24408-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/db975cfc6159/JCLA-36-e24408-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/5b92e67dc447/JCLA-36-e24408-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/77cb44b8f44e/JCLA-36-e24408-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/256d9961c149/JCLA-36-e24408-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/2d226406dc85/JCLA-36-e24408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/ca6de6973e02/JCLA-36-e24408-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/cd82085c25bc/JCLA-36-e24408-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/db975cfc6159/JCLA-36-e24408-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/5b92e67dc447/JCLA-36-e24408-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/77cb44b8f44e/JCLA-36-e24408-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/256d9961c149/JCLA-36-e24408-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/2d226406dc85/JCLA-36-e24408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6462/9102507/ca6de6973e02/JCLA-36-e24408-g001.jpg

相似文献

1
Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis.环状 RNA hsa_circ_0011298 通过调控 miR-486-3p/CRABP2 轴增强非小细胞肺癌对紫杉醇的耐药性。
J Clin Lab Anal. 2022 May;36(5):e24408. doi: 10.1002/jcla.24408. Epub 2022 Apr 8.
2
Circular RNA circ_0002360 regulates the Taxol resistance and malignant behaviors of Taxol-resistant non-small cell lung cancer cells by microRNA-585-3p-dependent modulation of G protein regulated inducer of neurite outgrowth 1.环状 RNA circ_0002360 通过 microRNA-585-3p 依赖性调控 G 蛋白调节的神经突生长诱导因子 1 来调节紫杉醇耐药的非小细胞肺癌细胞的紫杉醇耐药性和恶性行为。
Bioengineered. 2022 Apr;13(4):9070-9085. doi: 10.1080/21655979.2022.2053803.
3
Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.环状 RNA 0011292 通过调控 miR-433-3p/CHEK1 轴抑制紫杉醇耐药非小细胞肺癌的进展和耐药性。
Thorac Cancer. 2022 May;13(9):1276-1288. doi: 10.1111/1759-7714.14378. Epub 2022 Mar 29.
4
Circ_0058608 contributes to the progression and taxol resistance of non-small cell lung cancer by sponging miR-1299 to upregulate GBP1.环状 RNA 0058608 通过海绵吸附 miR-1299 来上调 GBP1 促进非小细胞肺癌的进展和紫杉醇耐药性。
Anticancer Drugs. 2023 Jan 1;34(1):103-114. doi: 10.1097/CAD.0000000000001346. Epub 2022 Nov 18.
5
circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.circ_0007385 作为竞争性内源性 RNA,与 miR-519d-3p 结合,抑制非小细胞肺癌细胞的恶性行为和顺铂耐药性。
Thorac Cancer. 2020 Aug;11(8):2196-2208. doi: 10.1111/1759-7714.13527. Epub 2020 Jun 29.
6
Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).Circ_0020123 通过海绵吸附 miR-140-3p 调控同源盒 B5(HOXB5)从而部分增强非小细胞肺癌细胞对顺铂的耐药性。
Bioengineered. 2022 Mar;13(3):5126-5140. doi: 10.1080/21655979.2022.2036910.
7
Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.hsa_circ_0007580 的下调通过减少 miR-545-3p 的海绵作用抑制非小细胞肺癌的肿瘤发生。
Aging (Albany NY). 2020 Jul 18;12(14):14329-14340. doi: 10.18632/aging.103472.
8
Circ_0001715 Functions as a miR-1249-3p Sponge to Accelerate the Progression of Non-small Cell Lung Cancer via Upregulating the Level of FGF5.环状 RNA 0001715 通过上调 FGF5 水平作为 miR-1249-3p 的海绵促进非小细胞肺癌的进展。
Biochem Genet. 2023 Oct;61(5):1807-1826. doi: 10.1007/s10528-023-10344-6. Epub 2023 Feb 21.
9
Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.环状 RNA circ_0058357 通过 miR-361-3p/ABCC1 轴调控顺铂耐药非小细胞肺癌细胞。
Thorac Cancer. 2021 Nov;12(21):2894-2906. doi: 10.1111/1759-7714.14150. Epub 2021 Sep 14.
10
circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).circ_PPAPDC1A 通过海绵吸附 miR-30a-3p/IGF1R 通路促进非小细胞肺癌(NSCLC)对奥希替尼的耐药性。
Mol Cancer. 2024 May 7;23(1):91. doi: 10.1186/s12943-024-01998-w.

引用本文的文献

1
Circular RNAs: key regulators of paclitaxel sensitivity and resistance in cancer.环状RNA:癌症中紫杉醇敏感性和耐药性的关键调节因子
Eur J Med Res. 2025 Aug 18;30(1):758. doi: 10.1186/s40001-025-03045-w.
2
Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic response.环状RNA-微小RNA网络在癌症发展和治疗反应中的新兴作用。
Noncoding RNA Res. 2024 Sep 11;10:98-115. doi: 10.1016/j.ncrna.2024.09.006. eCollection 2025 Feb.
3
Circular RNAs in lung cancer: implications for preventing therapeutic resistance.

本文引用的文献

1
CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid.CRABP1 和 CRABP2 蛋白水平相互关联,但与乳腺癌细胞对维甲酸的敏感性无关。
Biochemistry (Mosc). 2021 Feb;86(2):217-229. doi: 10.1134/S0006297921020103.
2
Overexpression of hsa_circ_0002874 promotes resistance of non-small cell lung cancer to paclitaxel by modulating miR-1273f/MDM2/p53 pathway.hsa_circ_0002874 的过表达通过调节 miR-1273f/MDM2/p53 通路促进非小细胞肺癌对紫杉醇的耐药性。
Aging (Albany NY). 2021 Feb 17;13(4):5986-6009. doi: 10.18632/aging.202521.
3
Circular RNA FLNA acts as a sponge of miR-486-3p in promoting lung cancer progression via regulating XRCC1 and CYP1A1.
环状 RNA 与肺癌:在预防治疗抵抗中的作用。
EBioMedicine. 2024 Sep;107:105309. doi: 10.1016/j.ebiom.2024.105309. Epub 2024 Aug 26.
4
Circ_0001786 facilitates gefitinib resistance and malignant progression in non-small cell lung cancer via miR-34b-5p/SRSF1.环状 RNA 0001786 通过 miR-34b-5p/SRSF1 促进非小细胞肺癌对吉非替尼的耐药性和恶性进展。
J Cardiothorac Surg. 2024 Apr 5;19(1):178. doi: 10.1186/s13019-024-02651-9.
5
Chemoresistance Mechanisms in Non-Small Cell Lung Cancer-Opportunities for Drug Repurposing.非小细胞肺癌中的化疗耐药机制——药物重新利用的机遇
Appl Biochem Biotechnol. 2024 Jul;196(7):4382-4438. doi: 10.1007/s12010-023-04595-7. Epub 2023 Sep 18.
6
The Molecular Pathogenesis of Tumor-Suppressive and Target Genes: Facilitates Aggressiveness in Lung Adenocarcinoma.肿瘤抑制基因和靶向基因的分子发病机制:促进肺腺癌的侵袭性。
Cells. 2023 Jul 18;12(14):1885. doi: 10.3390/cells12141885.
7
Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells.微小RNA在调控肺肿瘤细胞对阿霉素和紫杉醇反应中的作用
Cell Div. 2023 Jul 21;18(1):11. doi: 10.1186/s13008-023-00093-8.
8
The significance of the crosstalk between ubiquitination or deubiquitination and ncRNAs in non-small cell lung cancer.泛素化或去泛素化与非编码RNA在非小细胞肺癌中的相互作用的意义。
Front Oncol. 2023 Jan 16;12:969032. doi: 10.3389/fonc.2022.969032. eCollection 2022.
9
The emerging role of circular RNAs in drug resistance of non-small cell lung cancer.环状RNA在非小细胞肺癌耐药中的新作用
Front Oncol. 2022 Oct 11;12:1003230. doi: 10.3389/fonc.2022.1003230. eCollection 2022.
环形 RNA FLNA 通过调节 XRCC1 和 CYP1A1 作为 miR-486-3p 的海绵促进肺癌进展。
Cancer Gene Ther. 2022 Jan;29(1):101-121. doi: 10.1038/s41417-021-00293-w. Epub 2021 Jan 26.
4
Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p.环状ZFR通过海绵吸附miR-195-5p上调核转运蛋白α4,从而促进非小细胞肺癌的紫杉醇耐药性及进展。
Cancer Cell Int. 2021 Jan 6;21(1):15. doi: 10.1186/s12935-020-01702-0.
5
Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression.Hsa_circ_0001869 通过海绵吸附 miR-638 和增强 FOSL2 表达促进 NSCLC 进展。
Aging (Albany NY). 2020 Nov 20;12(23):23836-23848. doi: 10.18632/aging.104037.
6
Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.环状 RNA 0011292 通过调控 miR-379-5p/TRIM65 轴增强非小细胞肺癌对紫杉醇的耐药性。
Cancer Biother Radiopharm. 2022 Mar;37(2):84-95. doi: 10.1089/cbr.2019.3546. Epub 2020 Aug 20.
7
miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR.miR-486-3p 通过靶向 FGFR4 和 EGFR 介导肝癌索拉非尼耐药。
Cell Death Dis. 2020 Apr 20;11(4):250. doi: 10.1038/s41419-020-2413-4.
8
Circ-ABCB10 Contributes to Paclitaxel Resistance in Breast Cancer Through Let-7a-5p/DUSP7 Axis.环状ABCB10通过Let-7a-5p/DUSP7轴促进乳腺癌对紫杉醇的耐药性。
Cancer Manag Res. 2020 Mar 27;12:2327-2337. doi: 10.2147/CMAR.S238513. eCollection 2020.
9
Overexpression miR-486-3p Promoted by Allicin Enhances Temozolomide Sensitivity in Glioblastoma Via Targeting MGMT.蒜素过表达 miR-486-3p 通过靶向 MGMT 增强胶质母细胞瘤对替莫唑胺的敏感性。
Neuromolecular Med. 2020 Sep;22(3):359-369. doi: 10.1007/s12017-020-08592-5. Epub 2020 Feb 21.
10
regulates paclitaxel resistance in lung adenocarcinoma A549 cells.调节肺腺癌细胞 A549 中的紫杉醇耐药性。
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):639-647. doi: 10.1080/21691401.2020.1728287.